✦ LIBER ✦

TMC207: the first compound of a new class of potent anti-tuberculosis drugs

✍ Scribed by Matteelli, Alberto; Carvalho, Anna CC; Dooley, Kelly E; Kritski, Afranio

Book ID: 120247706
Publisher: Future Medicine
Year: 2010
Tongue: English
Weight: 503 KB
Volume: 5
Category: Article
ISSN: 1746-0913
DOI: 10.2217/fmb.10.50

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Review of the Evidence for Using Bedaq

A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis

✍ Gregory J. Fox, Dick Menzies 📂 Article 📅 2013 🏛 Springer Healthcare Communications 🌐 English ⚖ 600 KB

A Review of the Evidence for Using Bedaq

A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis

✍ Gregory J. Fox, Dick Menzies 📂 Article 📅 2013 🏛 Springer Healthcare Communications 🌐 English ⚖ 600 KB

Existing therapies for multi-drug resistant tuberculosis (MDR-TB) have substantial limitations, in terms of their effectiveness, side-effect profile, and complexity of administration. Bedaquiline is a novel diarylquinoline antibiotic that has recently been investigated as an adjunct to existing ther

The interaction of the diarylquinoline T

The interaction of the diarylquinoline TMC207, a new tuberculosis antibiotic, with its target mycobacterial ATP synthase

✍ Haagsma, A.C.; Lu, P.; Lill, H.; Bald, D. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 79 KB

First Synthesis of Aza-Calanolides — A N

First Synthesis of Aza-Calanolides — A New Class anti-HIV Active Compounds.

✍ G. V. Madhava Sharma; A. Ilangovan; Ven L. Narayanan; Mukund K. Gurjar 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 69 KB 👁 2 views

The first examples of ilexgenin A hybrid

The first examples of ilexgenin A hybrids as a new class of multi-potent, anti-platelet agents

✍ Lin, Li-Ping; Wu, Fei-Hua; Liang, Jing-Yu 📂 Article 📅 2013 🏛 Chinese Electronic Periodical Services 🌐 English ⚖ 398 KB

Synthesis and HPLC-purification of [77Br

Synthesis and HPLC-purification of [77Br]TMC125-R165335 (etravirine), a new anti-HIV drug of the DAPY-NNRTI class

✍ Bart De Spiegeleer; Filip Dumont; Kathelijne Peremans; Christian Burvenich; Liev 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 123 KB

77 Br]TMC125-R165335 (etravirine) was synthesized for imaging studies by SPECT. Labelling was performed with bromine-77 by electrophilic substitution of the desbromo-precursor 4-{6-amino-2-[(4-cyanophenyl)amino]pyrimidin-4-yloxy}-3,5dimethylbenzenecarbonitrile using carrier-free 77 Br À and chloram